Analytical and clinical evaluation of antibody tests for SARS-CoV-2 serosurveillance studies used in Finland in 2020

Nina Ekström, Camilla Virta, Anu Haveri, Timothée Dub, Lotta Hagberg, Anna Solastie, Pamela Österlund, Terhi Vihervaara, Iris Erlund, Hanna Nohynek, Merit Melin
doi: https://doi.org/10.1101/2021.01.21.21250207

Article Information

doi 
https://doi.org/10.1101/2021.01.21.21250207
History 
  • January 25, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Nina Ekström1,*,
  2. Camilla Virta1,
  3. Anu Haveri1,
  4. Timothée Dub1,
  5. Lotta Hagberg1,
  6. Anna Solastie1,
  7. Pamela Österlund1,
  8. Terhi Vihervaara2,
  9. Iris Erlund2,
  10. Hanna Nohynek1 and
  11. Merit Melin1
  1. 1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
  2. 2Department of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland
  1. ↵*Corresponding author: Nina Ekström, nina.ekstrom{at}thl.fi
Back to top
Posted January 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Analytical and clinical evaluation of antibody tests for SARS-CoV-2 serosurveillance studies used in Finland in 2020
Nina Ekström, Camilla Virta, Anu Haveri, Timothée Dub, Lotta Hagberg, Anna Solastie, Pamela Österlund, Terhi Vihervaara, Iris Erlund, Hanna Nohynek, Merit Melin
medRxiv 2021.01.21.21250207; doi: https://doi.org/10.1101/2021.01.21.21250207
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area